Variance in 30-day and 1-year RSM rates explained by each performance measure and the composite measure
| Measures | 30-day RSM rate | 1-year RSM rate |
| % variance explained | % variance explained | |
| Acute interventions | ||
| Intravenous rt-PA <2 hours | 2.43 | 1.32 |
| Early antithrombotics | 0.04 | 0.08 |
| DVT prophylaxis | 0.38 | 1.14 |
| Discharge interventions | ||
| Discharge antithrombotics | 2.59 | 10.05 |
| Anticoagulation for AF | 0.14 | 0.45 |
| LDL 100 | 0.76 | 4.67 |
| Antihypertensive medication | 2.99 | 9.24 |
| Antidiabetic medication | 5.02 | 9.49 |
| Smoking cessation | 0.18 | 0.06 |
| Composite score | 2.53 | 10.18 |
AF, atrial fibrillation; DVT, deep vein thrombosis; LDL, low-density lipoprotein; RSM, risk-standardised mortality; rt-PA, recombinant tissue-type plasminogen activator.